Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
Pt 3
pubmed:dateCreated
2003-6-16
pubmed:databankReference
pubmed:abstractText
Strain HAG 010767(T) was isolated from desert soil from Namibia during a screening programme. On the basis of analysis of 16S rDNA, the principal amino acid of the peptidoglycan, cell-wall sugars, fatty acids and polar lipids, it was possible to identify this strain as a member of the genus Actinomadura. Although DNA-DNA reassociation experiments revealed 72% DNA similarity between strain HAG 010767(T) and Actinomadura kijaniata DSM 43764(T), significant differences in the colour of the mycelium and physiological properties indicate that strain HAG 010767(T) represents a novel species of this genus, for which the name Actinomadura namibiensis sp. nov. is proposed. The type strain is strain HAG 010767(T) (= DSM 44197(T) = NRRL B-24153(T)).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1466-5026
pubmed:author
pubmed:issnType
Print
pubmed:volume
53
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
721-4
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
2003
pubmed:articleTitle
Actinomadura namibiensis sp. nov.
pubmed:affiliation
Aventis Pharma Deutschland, Drug Innovation and Approval, Natural Products, 65926 Frankfurt, Germany. Joachim.Wink@aventis.com
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, U.S. Gov't, Non-P.H.S., Research Support, Non-U.S. Gov't